Search Results

There are 12868 results for: content related to: CD22 ligation inhibits downstream B cell receptor signaling and Ca 2+ flux upon activation

  1. You have free access to this content
    Nanoscale organization and dynamics of the siglec CD22 cooperate with the cytoskeleton in restraining BCR signalling

    The EMBO Journal

    Volume 35, Issue 3, 1 February 2016, Pages: 258–280, Francesca Gasparrini, Christoph Feest, Andreas Bruckbauer, Pieta K Mattila, Jennifer Müller, Lars Nitschke, Dennis Bray and Facundo D Batista

    Version of Record online : 15 DEC 2015, DOI: 10.15252/embj.201593027

  2. You have free access to this content
    Enhanced Tyrosine Phosphatase Activity Underlies Dysregulated B Cell Receptor Signaling and Promotes Survival of Human Lupus B Cells

    Arthritis & Rheumatology

    Volume 68, Issue 5, May 2016, Pages: 1210–1221, Sarah J. Fleischer, Capucine Daridon, Vanessa Fleischer, Peter E. Lipsky and Thomas Dörner

    Version of Record online : 27 APR 2016, DOI: 10.1002/art.39559

  3. Epratuzumab modulates B-cell signaling without affecting B-cell numbers or B-cell functions in a mouse model with humanized CD22

    European Journal of Immunology

    Volume 46, Issue 9, September 2016, Pages: 2260–2272, Lamia Özgör, Carolin Brandl, Anthony Shock and Lars Nitschke

    Version of Record online : 25 JUL 2016, DOI: 10.1002/eji.201646383

  4. You have free access to this content
    CD22 expression on blastic plasmacytoid dendritic cell neoplasms and reactivity of anti-CD22 antibodies to peripheral blood dendritic cells

    Cytometry Part B: Clinical Cytometry

    Volume 76B, Issue 4, July 2009, Pages: 237–248, Edmunds Z. Reineks, Ebenezer S Osei, Arlene Rosenberg, Jeffrey Auletta and Howard J. Meyerson

    Version of Record online : 20 APR 2009, DOI: 10.1002/cyto.b.20469

  5. You have free access to this content
    Human CD22 cannot fully substitute murine CD22 functions in vivo, as shown in a new knockin mouse model

    European Journal of Immunology

    Volume 42, Issue 11, November 2012, Pages: 3009–3018, Miriam Wöhner, Stefanie Born and Lars Nitschke

    Version of Record online : 17 OCT 2012, DOI: 10.1002/eji.201242629

  6. You have free access to this content
    Autoantibody-mediated regulation of B cell responses by functional anti-CD22 autoantibodies in patients with systemic sclerosis

    Clinical & Experimental Immunology

    Volume 159, Issue 2, February 2010, Pages: 176–184, M. Odaka, M. Hasegawa, Y. Hamaguchi, N. Ishiura, S. Kumada, T. Matsushita, K. Komura, S. Sato, K. Takehara and M. Fujimoto

    Version of Record online : 16 NOV 2009, DOI: 10.1111/j.1365-2249.2009.04059.x

  7. Characterization of CD22 expression in acute lymphoblastic leukemia

    Pediatric Blood & Cancer

    Volume 62, Issue 6, June 2015, Pages: 964–969, Nirali N. Shah, Maryalice Stetler Stevenson, Constance M. Yuan, Kelly Richards, Cindy Delbrook, Robert J. Kreitman, Ira Pastan and Alan S. Wayne

    Version of Record online : 1 MAR 2015, DOI: 10.1002/pbc.25410

  8. Re-induction chemoimmunotherapy with epratuzumab in relapsed acute lymphoblastic leukemia (ALL): Phase II results from Children's Oncology Group (COG) study ADVL04P2

    Pediatric Blood & Cancer

    Volume 62, Issue 7, July 2015, Pages: 1171–1175, Elizabeth A. Raetz, Mitchell S. Cairo, Michael J. Borowitz, Xiaomin Lu, Meenakshi Devidas, Joel M. Reid, David M. Goldenberg, William A. Wegener, Hui Zeng, James A. Whitlock, Peter C. Adamson, Stephen P. Hunger and William L. Carroll

    Version of Record online : 2 MAR 2015, DOI: 10.1002/pbc.25454

  9. CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions

    Immunological Reviews

    Volume 230, Issue 1, July 2009, Pages: 128–143, Lars Nitschke

    Version of Record online : 29 JUN 2009, DOI: 10.1111/j.1600-065X.2009.00801.x

  10. You have free access to this content
    Treatment of systemic lupus erythematosus with epratuzumab

    British Journal of Clinical Pharmacology

    Volume 71, Issue 2, February 2011, Pages: 175–182, Pawel Traczewski and Lidia Rudnicka

    Version of Record online : 28 JUL 2010, DOI: 10.1111/j.1365-2125.2010.03767.x

  11. You have free access to this content
    Targeting of CD22-positive B-cell lymphoma cells by synthetic divalent sialic acid analogues

    European Journal of Immunology

    Volume 42, Issue 10, October 2012, Pages: 2792–2802, Astrid Schweizer, Miriam Wöhner, Horst Prescher, Reinhard Brossmer and Lars Nitschke

    Version of Record online : 6 AUG 2012, DOI: 10.1002/eji.201242574

  12. You have free access to this content
    CD22: an inhibitory enigma

    Immunology

    Volume 123, Issue 3, March 2008, Pages: 314–325, Jennifer A. Walker and Kenneth G. C. Smith

    Version of Record online : 7 DEC 2007, DOI: 10.1111/j.1365-2567.2007.02752.x

  13. Sialic acids and autoimmune disease

    Immunological Reviews

    Volume 269, Issue 1, January 2016, Pages: 145–161, Vinay S. Mahajan and Shiv Pillai

    Version of Record online : 19 DEC 2015, DOI: 10.1111/imr.12344

  14. You have free access to this content
    DropArray™, a Wall-Less 96-Well Plate for Uptake and Immunofluorescence Microscopy, Confirms CD22 Recycles

    Traffic

    Volume 15, Issue 3, March 2014, Pages: 255–272, Gladys S. Ingle and Suzie J. Scales

    Version of Record online : 14 JAN 2014, DOI: 10.1111/tra.12144

  15. You have free access to this content
    ACR Meeting

    Arthritis & Rheumatism

    Volume 64, Issue S10, October 2012, Pages: S1–S1216,

    Version of Record online : 11 OCT 2012, DOI: 10.1002/art.37735

  16. You have free access to this content
    B cell defects in SLP65/BLNK-deficient mice can be partially corrected by the absence of CD22, an inhibitory coreceptor for BCR signaling

    European Journal of Immunology

    Volume 33, Issue 12, December 2003, Pages: 3418–3426, Judith Gerlach, Snigdha Ghosh, Hassan Jumaa, Michael Reth, Jürgen Wienands, Andrew C. Chan and Lars Nitschke

    Version of Record online : 10 NOV 2003, DOI: 10.1002/eji.200324290

  17. You have free access to this content
    Analysis of Lyn/CD22 double-deficient B cells in vivo demonstrates Lyn- and CD22-independent pathways affecting BCR regulation and B cell survival

    European Journal of Immunology

    Volume 35, Issue 12, December 2005, Pages: 3655–3663, Helen Ferry, Tanya L. Cockford, Karlee Silver, Nigel Rust, Christopher C. Goodnow and Richard J. Cornall

    Version of Record online : 8 NOV 2005, DOI: 10.1002/eji.200535247

  18. You have free access to this content
    Current status of antibody therapy in ALL

    British Journal of Haematology

    Volume 168, Issue 4, February 2015, Pages: 471–480, Jing Ai and Anjali Advani

    Version of Record online : 10 NOV 2014, DOI: 10.1111/bjh.13205

  19. You have free access to this content
    A novel subset of murine B cells that expresses unmasked forms of CD22 is enriched in the bone marrow: implications for B-cell homing to the bone marrow

    Immunology

    Volume 101, Issue 3, November 2000, Pages: 342–347, H. Floyd, L. Nitschke and P. R. Crocker

    Version of Record online : 9 OCT 2008, DOI: 10.1046/j.1365-2567.2000.00103.x

  20. You have full text access to this OnlineOpen article
    Internalization of Rituximab and the Efficiency of B Cell Depletion in Rheumatoid Arthritis and Systemic Lupus Erythematosus

    Arthritis & Rheumatology

    Volume 67, Issue 8, August 2015, Pages: 2046–2055, Venkat Reddy, Geraldine Cambridge, David A. Isenberg, Martin J. Glennie, Mark S. Cragg and Maria Leandro

    Version of Record online : 28 JUL 2015, DOI: 10.1002/art.39167